Compared to the estimated level at the onset, serum NfL in PD group showed an increase of 153% over the 30 years of symptomatic period (Fig. 2E), which was larger change than CSF Aβ1-42, α-syn, t-tau and p-tau. This evidence concerns the gene MAPT and Parkinson disease.